Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.
Etest is a new concept for MIC determinations for antimicrobial agents that is based on a predefined antibiotic gradient on a plastic strip calibrated with a continuous logarithmic MIC scale covering 15 twofold dilutions. Etest was compared with a reference agar dilution method for susceptibility testing of clinical isolates of Mycobacterium chelonae and M. fortuitum. Results read after 3 days showed good agreement between MICs obtained with Etest and those obtained with the reference method within +/- 2 dilutions for 90% of all test combinations. All but one of the strains were inhibited by low concentrations of ciprofloxacin or amikacin. Susceptibility to clarithromycin, erythromycin, imipenem, rifampin, doxycycline, and fusidic acid was variable, and all strains were resistant to ceftazidime and trimethoprim. The results suggest that Etest is well suited for studies of drug resistance in rapidly growing mycobacteria.
Hoffner
S E
SE
Microbiological and Tumorbiological Center, Karolinska Institute, Stockholm, Sweden.
Klintz
L
L
Olsson-Liljequist
B
B
Bolmström
A
A
D000583:Amikacin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009161:Mycobacterium / Q000187:drug effects*; D009164:Mycobacterium Infections / Q000382:microbiology; D016926:Mycobacterium chelonae / Q000187:drug effects
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D000583:Amikacin